Conference item
Delayed oral toxicity from long term Vemurafenib therapy
- Abstract:
-
We read with interest the article by Vigarios et al.1 describing eight patients treated with a variety of BRAF inhibitors who developed asymptomatic hyperkeratotic oral mucosal lesions. These were frequently multifocal and presented following a mean onset of three months of treatment with a BRAF inhibitor. In one patient, one such lesion rapidly developed into oral squamous cell carcinoma requiring excision. We would like to highlight delayed oral toxicity in a long-term responder to a BRAF inhibitor.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 304.7KB, Terms of use)
-
- Publisher copy:
- 10.1111/bjd.14457
Authors
- Publisher:
- Wiley
- Host title:
- British Journal of Dermatology
- Journal:
- British Journal of Dermatology More from this journal
- Volume:
- 174
- Issue:
- 5
- Pages:
- 1159-1160
- Publication date:
- 2016-05-01
- Acceptance date:
- 2016-01-11
- DOI:
- EISSN:
-
1365-2133
- ISSN:
-
0007-0963
- Pubs id:
-
pubs:606574
- UUID:
-
uuid:e7fc5422-5698-4a8b-9793-ab69affd5dbd
- Local pid:
-
pubs:606574
- Source identifiers:
-
606574
- Deposit date:
-
2016-02-26
Terms of use
- Copyright holder:
- British Association of Dermatologists
- Copyright date:
- 2016
- Notes:
- © 2016 British Association of Dermatologists. This is the accepted manuscript version of the article. The final version is available online from Wiley at: https://doi.org/10.1111/bjd.14457
If you are the owner of this record, you can report an update to it here: Report update to this record